Medina, D., Kittrell, F., Hill, J., Zhang, Y., Hilsenbeck, S., Bissonette, R., & Brown, P. (2009). Prevention of tumorigenesis in p53 null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib and celecoxib.

Medina, D., F. Kittrell, J. Hill, Y. Zhang, S. Hilsenbeck, R. Bissonette, a P.H Brown. Prevention of Tumorigenesis in P53 Null Mammary Epithelium By Rexinoid Bexarotene, Tyrosine Kinase Inhibitor Gefitinib and Celecoxib. 2009.

Medina, D., et al. Prevention of Tumorigenesis in P53 Null Mammary Epithelium By Rexinoid Bexarotene, Tyrosine Kinase Inhibitor Gefitinib and Celecoxib. 2009.